Honliv Healthcare Management Group Company Limited (HKG:9906)
Hong Kong · Delayed Price · Currency is HKD 1.560
-0.060 (-3.70%)
Mar 4, 2026, 2:24 PM HKT
HKG:9906 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 3, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 857 | 1,248 | 1,596 | 1,464 | 1,512 | 1,236 | |
Market Cap Growth | -5.87% | -21.80% | 9.02% | -3.17% | 22.33% | - |
Enterprise Value | 698 | 1,158 | 1,490 | 1,342 | 1,453 | 1,429 |
Last Close Price | 1.56 | 2.08 | 2.66 | 2.44 | 2.52 | 2.06 |
Price Ratios
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 3, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
PE Ratio | 74.43 | 37.65 | 37.82 | 26.46 | 33.64 | 47.65 |
PS Ratio | 1.12 | 1.53 | 1.91 | 1.78 | 2.03 | 1.99 |
PB Ratio | 1.39 | 2.03 | 2.65 | 2.34 | 2.17 | 1.97 |
P/TBV Ratio | 1.41 | 2.05 | 2.68 | 2.36 | 2.19 | 1.98 |
P/FCF Ratio | 11.32 | 34.83 | 628.23 | 13.01 | 30.47 | - |
P/OCF Ratio | 7.33 | 14.07 | 15.82 | 10.93 | 13.47 | 13.95 |
EV Ratios
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 3, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
EV/Sales Ratio | 0.91 | 1.42 | 1.78 | 1.63 | 1.95 | 2.30 |
EV/EBITDA Ratio | 6.68 | 9.20 | 11.93 | 10.15 | 12.37 | 13.99 |
EV/EBIT Ratio | 30.64 | 22.15 | 23.54 | 17.98 | 17.77 | 19.42 |
EV/FCF Ratio | 9.22 | 32.33 | 586.56 | 11.92 | 29.29 | - |
Financial Efficiency
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 3, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Debt / Equity Ratio | 0.24 | 0.30 | 0.33 | 0.26 | 0.33 | 0.47 |
Debt / EBITDA Ratio | 1.43 | 1.44 | 1.54 | 1.18 | 1.88 | 2.76 |
Debt / FCF Ratio | 1.97 | 5.23 | 78.39 | 1.44 | 4.66 | - |
Net Debt / Equity Ratio | -0.27 | -0.14 | -0.11 | -0.20 | -0.13 | -0.10 |
Net Debt / EBITDA Ratio | -1.65 | -0.70 | -0.52 | -0.96 | -0.78 | -0.61 |
Net Debt / FCF Ratio | -2.18 | -2.45 | -25.58 | -1.13 | -1.86 | 9.01 |
Asset Turnover | 0.74 | 0.79 | 0.80 | 0.77 | 0.63 | 0.62 |
Inventory Turnover | 31.02 | 17.98 | 20.07 | 20.66 | 19.71 | 17.63 |
Quick Ratio | 0.98 | 0.90 | 0.69 | 0.80 | 0.76 | 0.73 |
Current Ratio | 1.03 | 1.01 | 0.85 | 0.88 | 0.83 | 0.80 |
Return on Equity (ROE) | 1.87% | 5.59% | 7.02% | 8.80% | 6.75% | 5.75% |
Return on Assets (ROA) | 1.38% | 3.16% | 3.77% | 4.35% | 4.31% | 4.56% |
Return on Invested Capital (ROIC) | 3.84% | 7.36% | 9.29% | 11.07% | 10.07% | 10.01% |
Return on Capital Employed (ROCE) | 3.60% | 8.30% | 10.00% | 11.80% | 11.70% | 11.60% |
Yields
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 3, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Earnings Yield | 1.33% | 2.66% | 2.64% | 3.78% | 2.97% | 2.10% |
FCF Yield | 8.83% | 2.87% | 0.16% | 7.69% | 3.28% | -0.56% |
Payout Ratio | - | - | - | - | - | 33.09% |
Buyback Yield / Dilution | 5.05% | 6.01% | 1.31% | 1.32% | -15.28% | -16.25% |